| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,340,000,000 |
| Market
Cap: |
112.96(B) |
| Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
| 52
Week Range: |
$69.43 - $90.4 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 125 |
| Guru Rank Value : 7.5 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,549 |
36,546 |
56,412 |
75,447 |
| Total Sell Value |
$2,684,057 |
$3,094,660 |
$4,783,517 |
$6,318,268 |
| Total People Sold |
2 |
3 |
5 |
5 |
| Total Sell Transactions |
2 |
3 |
8 |
10 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pozen Robert C |
Director |
• • – |
2018-08-23 |
4 |
OE |
$29.96 |
$160,031 |
D/D |
4,484 |
64,182 |
|
- |
|
| Anderson Richard H |
Director |
• • – |
2018-08-23 |
4 |
B |
$95.88 |
$249,285 |
D/D |
2,600 |
76,920 |
2.39 |
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2018-08-22 |
4 |
S |
$95.50 |
$13,899,161 |
D/D |
(145,544) |
200,180 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2018-08-22 |
4 |
OE |
$34.88 |
$6,596,044 |
D/D |
178,219 |
345,724 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2018-08-03 |
4 |
D |
$90.48 |
$526,413 |
D/D |
(5,818) |
57,653 |
|
- |
|
| Martha Geoffrey |
EVP & GroupPres Restora Therap |
• • – |
2018-08-03 |
4 |
D |
$90.48 |
$432,494 |
D/D |
(4,780) |
59,202 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2018-08-03 |
4 |
D |
$90.48 |
$686,291 |
D/D |
(7,585) |
167,505 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2018-08-03 |
4 |
D |
$90.48 |
$357,758 |
D/D |
(3,954) |
67,108 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2018-08-03 |
4 |
D |
$90.48 |
$2,443,865 |
D/D |
(27,010) |
561,816 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2018-08-03 |
4 |
D |
$90.48 |
$376,035 |
D/D |
(4,156) |
42,499 |
|
- |
|
| White Robert John |
EVP & President MITG |
• • – |
2018-08-03 |
4 |
D |
$90.48 |
$253,887 |
D/D |
(2,806) |
49,074 |
|
- |
|
| Kuntz Richard |
SVP & Chief Medical & Science |
• • – |
2018-08-03 |
4 |
D |
$90.48 |
$451,224 |
D/D |
(4,987) |
111,352 |
|
- |
|
| Hakami Hooman |
EVP & Group President Diabetes |
• • – |
2018-08-03 |
4 |
D |
$90.48 |
$436,295 |
D/D |
(4,822) |
62,647 |
|
- |
|
| White Robert John |
EVP & President MITG |
• • – |
2018-08-01 |
4 |
D |
$90.24 |
$18,680 |
D/D |
(207) |
51,879 |
|
- |
|
| Hakami Hooman |
EVP & Group President Diabetes |
• • – |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
9,355 |
66,472 |
|
- |
|
| Martha Geoffrey |
EVP & GroupPres Restora Therap |
• • – |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
11,226 |
63,981 |
|
- |
|
| Kuntz Richard |
SVP & Chief Medical & Science |
• • – |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,104 |
116,339 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
16,465 |
175,089 |
|
- |
|
| White Robert John |
EVP & President MITG |
• • – |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,478 |
52,086 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
50,517 |
588,826 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
9,730 |
71,062 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
14,089 |
80,371 |
|
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,233 |
46,654 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2018-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
11,226 |
63,471 |
|
- |
|
| Hakami Hooman |
EVP & Group President Diabetes |
• • – |
2018-07-28 |
4/A |
D |
$88.66 |
$801,664 |
D/D |
(9,042) |
58,113 |
|
- |
|
700 Records found
|
|
Page 17 of 28 |
|
|
0.78 (0.93%) 
